R&D Systems Inc. Tocris Bioscience Boston Biochem

G Proteins (Small)

Supporting information

Small G proteins (small GTPases) are homologous to Gα proteins and are often referred to as the Ras proto-oncogene superfamily. The Ras superfamily contains over 100 small GTPases grouped into eight families; Ras, Rho, Rab, Rap, Arf, Ran, Rheb and Rad. Small GTPases regulate a wide variety of processes in the cell, including growth, differentiation, movement and lipid vesicle transport.

Like Gα proteins, small GTPases alternate between an 'on' state (bound to GTP) and an 'off' state (bound to GDP). This cyclic process requires guanine nucleotide exchange factor (GEF) and GTPase-activating protein (GAP). Small GTPases are the downstream effectors of most receptor tyrosine kinases (RTKs) and are linked via two proteins, GRB2 and SOS. They are coupled to intracellular signaling cascades including the MAPK pathway, through interactions with Raf kinase. Normally, activation of small GTPases is induced by ligand binding to a RTK. In many transformed cells activating mutations of GTPases, often Ras, produce a cellular response in the absence of a ligand, thus promoting malignant progression.

View all products for G Proteins (Small) »
Gene Species Gene Symbol Gene Accession No. Protein Accession No.
H-Ras Human HRAS NM_176795 P01112
Mouse Hras1 NM_001130444 Q61411
Rat Hras NM_001098241 P20171
K-Ras Human KRAS NM_033360 P01116
Mouse Kras NM_021284 P32883
Rat Kras NM_031515 P08644
View all G Protein (Small) Gene Data »

Literature for G Proteins (Small)

Cancer Research Guide

Request Cancer Research Guide

A collection of over 350 products for cancer research, the guide contains modulators of:

  • Receptor Signaling
  • Cell Cycle and DNA Damage Repair
  • Cell Death and Drug Resistance
  • Angiogenesis
  • Invasion and Metastasis
Request copy | Download PDF

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Guide

Request your free copy

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions